REGN Competitors & Alternatives
Compare Regeneron Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
REGN
Main Stock$735.20
Tradestie Score
48
Market Cap
$63.59B
P/E Ratio
18.8
Revenue Growth
0.2%
Analyst Upside
+16.0%
Top Competitors
229 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals Inc
|
$504.73
|
$103.64B | 29.7 | 55 | Compare |
|
ALNY
Alnylam Pharmaceuticals, Inc.
|
$219.72
|
$60.38B | 42.9 | 49 | Compare |
|
ARGX
argenx SE American Depositary Shares
|
$919.21
|
$46.96B | 35.7 | 52 | Compare |
|
ONC
BeOne Medicines Ltd. American Depositary Shares
|
$358.07
|
$36.81B | 64.1 | 56 | Compare |
|
INSM
Insmed, Inc.
|
$111.12
|
$31.13B | - | 49 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$96.90
|
$24.57B | - | 55 | Compare |
|
BIIB
Biogen Inc. Common Stock
|
$219.88
|
$22.61B | 39.6 | 48 | Compare |
|
GMAB
Genmab A/S ADS
|
$34.75
|
$19.56B | 27.2 | 47 | Compare |
|
INCY
Incyte Genomics Inc
|
$115.30
|
$16.93B | 15.5 | 56 | Compare |
|
ILMN
Illumina Inc
|
$273.04
|
$15.72B | 49.6 | 37 | Compare |
More REGN Analysis
Data updated: Oct 02, 2026 | Industry: Biotechnology (SIC 2834)
229 stocks in this industry